Constraint-Induced Movement Therapy and Action Observation Training in Children With Unilateral Cerebral Palsy

October 25, 2019 updated by: Klingels Katrijn, KU Leuven

Effectiveness of Intensive Upper Limb Training Combining Constraint-Induced Movement Therapy and Action Observation Training in Children With Unilateral Cerebral Palsy

A randomized, controlled, and evaluator-blinded trail will be carried out comparing CIMT with or without AOT on sensorimotor outcome in children with unilateral CP aged 5 to 12 years. Additionally the potential role of neurological factors, including the anatomical characterization of the brain lesion, structural/functional connectivity and cortical reorganization, on treatment response will be investigated.

Study Overview

Detailed Description

Background: Problems in upper limb (UL) function in children with unilateral cerebral palsy (UCP) are traditionally trained with motor execution treatment models, such as Constraint Induced Movement Therapy (CIMT). However new approaches based on a neurophysiological model such as action observation training (AOT) may provide new opportunities for enhanced motor learning.

Aim: The aim of study is to investigate the effects of an intensive treatment model consisting of CIMT and AOT compared to CIMT alone on UL function in children with UCP. Additionally the potential role of neurological factors (including the anatomical characterization of the brain lesion, structural/functional connectivity and cortical reorganization) on treatment response will be analysed.

Methods/Design: A randomized, controlled, evaluator-blinded trial (RCT) will be conducted in 40 children between 5 and 12 years of age. Before randomization, children are stratified according to their House Functional Classification Scale, age and type of cortical reorganization. The Intervention is accomplished during a 2-week day camp in which the children receive intensive therapy for six hours a day on 9 out of 11 consecutive days (54 h) including AOT or placebo observation training (POT) (15h). During the AOT the children in the experimental group watch video sequences showing goal-directed actions and subsequently execute the observed actions with the affected UL. Children in the POT group perform the same actions after watching computer games without biological movements.

Outcome assessments include qualitative and quantitative measures of UL sensorimotor function across the International Classification of Functioning, Disability and Health (ICF). The primary outcome measure is the Assisting Hand Assessment (AHA). The medical imaging protocol includes structural Magnetic Resonance Imaging (MRI), Diffusion Kurtosis Imaging (DKI), resting state functional MRI (rs-fMRI) and Transcranial magnetic stimulation (TMS). The timeline for the assessment is T0 (1-1.5 month before the camp onset), T1 (before the intervention), T2 (after the intervention) and T3 (6 months after the intervention). Linear mixed models will be used to study time effects of the interventions and the interaction with neurological variables as covariates.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium, 3000
        • KU Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • confirmed diagnosis of unilateral CP
  • aged 5-12 years
  • sufficient cooperation to comprehend and complete the test procedure
  • minimal ability to actively grasp and stabilize an object

Exclusion Criteria:

  • upper limb surgery two years prior to enrollment
  • botulinum toxin A injections six months prior to enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: CIMT + AOT

In a 2-week day camp model children receive constraint-induced movement therapy for six hours a day, for 9 out of 11 consecutive days. All children wear a tailor made hand splint on the unaffected upper limb for 6 hours per day while performing unimanual exercises individually or in a group based on shaping and repetitive practice.

Action observation training consists of 15 sessions of 1 hour. Children watch video sequences showing goal-directed actions and subsequently execute the observed actions with the affected upper limb.

In a 2-week day camp model children receive constraint- induced movement therapy for six hours a day, for 9 out of 11 consecutive days. All children wear a tailor made hand splint on the unaffected upper limb for 6 hours per day while performing unimanual exercises individually or in a group based on shaping and repetitive practice.
Action observation training consists of 15 sessions of 1 hour. Children watch 3 minute video clips of unimanual goal-directed actions followed by 3 minutes of execution of the actions.
Placebo Comparator: CIMT + POT

In a 2-week day camp model children receive constraint- induced movement therapy for six hours a day, for 9 out of 11 consecutive days. All children wear a tailor made hand splint on the unaffected upper limb for 6 hours per day while performing unimanual exercises individually or in a group based on shaping and repetitive practice.

Placebo observation training consists of 15 sessions of 1 hour.This group performs the same actions after watching computer games without biological movements.

In a 2-week day camp model children receive constraint- induced movement therapy for six hours a day, for 9 out of 11 consecutive days. All children wear a tailor made hand splint on the unaffected upper limb for 6 hours per day while performing unimanual exercises individually or in a group based on shaping and repetitive practice.
Placebo observation training consists of 15 sessions of 1 hour. Children perform the same actions as the AOT training after watching computer games without biological movements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Assisting Hand Assessment (AHA)
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
The AHA, a Rasch-based performance scale, measures how effectively the affected hand is spontaneously used during performance of bimanual tasks.
baseline, pre and post intervention (within one week), 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Melbourne Assessment of Unilateral Upper Limb Function
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
The Melbourne Assessment evaluates quality of movement in 16 functional unimanual tasks.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in Jebsen-Taylor Hand Function Test
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
The Jebsen-Taylor hand function test measures manual dexterity in six unimanual tasks, by means of movement time expressed in seconds for both hands.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in Tyneside Pegboard test
Time Frame: pre and post intervention (within one week), 6 months follow-up
The Tyneside pegboard test is an adapted 9-hole pegboard test and assesses unimanual and bimanual dexterity.
pre and post intervention (within one week), 6 months follow-up
Change in passive range of motion (PROM)
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
PROM of shoulder flexion, abduction, external and internal rotation, elbow extension, forearm supination and wrist extension is measured using a universal goniometer.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in muscle tone
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
Muscle tone is evaluated in 11 muscle groups using the Modified Ashworth Scale (MAS), ranging from 0 to 4.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in muscle strength
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
Muscle strength is evaluated in nine muscle groups using manual muscle testing (MMT), ranging from 0 to 5.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in grip strength
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
Grip strength is assessed with a Jamar dynamometer®. The average of three consecutive maximum contractions is recorded for both hands.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in muscle fatigability
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
Muscle fatigability during an isometric grip strength task is assessed based on a 30 second sustained contraction with E-link software.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in Abilhand-Kids questionnaire
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
The Abilhand- Kids questionnaire is a Rasch-based inventory of 21 mostly bimanual activities that the parents are asked to judge as: 0 (impossible), 1 (difficult), and 2 (easy), irrespective of the limb(s) actually used to do the activity.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in Children's Hand-use Experience Questionnaire (CHEQ)
Time Frame: baseline, pre and post intervention (within one week), 6 months follow-up
CHEQ is a questionnaire to evaluate the experience of children and adolescents in using the affected hand in activities where usually two hands are needed.
baseline, pre and post intervention (within one week), 6 months follow-up
Change in Upper limb Three-dimensional movement analysis (3DMA)
Time Frame: pre and post intervention (within one week), 6 months follow-up
This quantitative assessment comprises upper limb kinematics during functionally relevant aiming and grasping tasks.
pre and post intervention (within one week), 6 months follow-up
Change in Assessment of Life Habits for children (LIFE-H Kids)
Time Frame: pre intervention (within one week), 6 months follow-up
LIFE-H Kids assesses the quality of social participation of children with disabilities by estimating how a client accomplishes activities of daily living and social roles
pre intervention (within one week), 6 months follow-up
Change in Cerebral Palsy Quality of Life Questionnaire (CP-QOL)
Time Frame: pre intervention (within one week), 6 months follow-up
CP-QOL is a parent report that assesses the wellbeing across various domains of life in children with cerebral palsy.
pre intervention (within one week), 6 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structural Magnetic Resonance Imaging (MRI)
Time Frame: baseline
Structural images are acquired using three-dimensional fluid-attenuated inversion recovery (3D FLAIR) with following parameters: 321 sagittal slices, slice thickness 1.2, slice gap 0.6, repetition time=4800 ms, echo time=353 ms, field of view=250 x 250 mm², 1.1 x 1.1 x 0.56 mm³ voxel size, acq time = 5'02". Brain lesions will be first classified according to the timing of the lesion and the predominant pattern of damage as described by Kragelöh-mann (2007): cortical malformations (first and second trimester of pregnancy), periventricular white matter (PWM) lesions (from late second till early third trimester) and cortical and deep greymatter (CDGM) lesions (around term age) and acquired brain lesions (between 28 days 3 years postnatally). Second, a more detailed evaluation of the brain lesion (i.e. location and extent) will be performed using the semi-quantitative MRI (sqMRI) scale developed by Fiori et al. (2014).
baseline
Resting state functional Magnetic Resonance Imaging (rsfMRI)
Time Frame: baseline
rsfMRI images are acquired using a T2*-weighted gradient-echo planar imaging (GE-EPI) sequence with the following parameters: TR = 1700 ms; TE = 30 ms; matrix size = 64x64; FOV = 230 mm; flip angle = 90º; slice thickness = 4 mm; no gap; axial slices = 30; number of functional volumes = 250; acquisition time = 7 min. rsfMRI will be pre-processed with Statistical Parametric Mapping version 12 (SPM12) software. Functional connectivity analysis will be computed with the CONN toolbox v17b.
baseline
Diffusion weighted imaging
Time Frame: baseline
Diffusion weighted images will be acquired using a single shot spin echo sequence with the following parameters: slice thickness = 2.5 mm, TR = 8700 ms, TE = 116 ms, number of diffusion directions = 150, number of sagittal slices = 58, voxel size = 2.5 x 2.5 x 2.5 mm³, acq time = 18'. Implemented b values are 700, 1000, and 2800 s/mm², applied in 25, 40, and 75 uniformly distributed directions, respectively. In addition, 11 non-diffusion weighted images are obtained. Diffusion data will be pre-processed and analyzed in ExploreDTI toolbox, version 4.8.6. Diffusion metrics, such as fractional anisotropy and mean diffusivity of white matter tracts of interest (i.e. corpus callosum, corticospinal tract, superior thalamic radiations, medial lemniscus) will be calculated for both hemispheres.
baseline
Transcranial Magnetic Stimulation (TMS)
Time Frame: baseline
TMS was performed using a MagStim 200 Stimulator (Magstim Ltd, Whitland, Wales, UK) equipped with a focal 70mm figure-eight coil and a Bagnoli electromyography (EMG) system with two single differential surface electrodes (Delsys Inc, Natick, MA, USA). A Micro1401-3 acquisition unit and Spike software version 4.11 (Cambridge Electronic Design Limited, Cambridge, UK) were used to synchronize the TMS stimuli and the EMG data acquisition. Motor Evoked Potentials (MEPs) were bilaterally recorded, using single differential surface EMG electrodes attached on the muscles adductor pollicis brevis of both hands.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Cristina Simon-Martinez, KU Leuven
  • Study Director: Hilde Feys, Prof, KU Leuven

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2014

Primary Completion (Actual)

February 28, 2018

Study Completion (Actual)

February 28, 2018

Study Registration Dates

First Submitted

July 14, 2017

First Submitted That Met QC Criteria

August 17, 2017

First Posted (Actual)

August 22, 2017

Study Record Updates

Last Update Posted (Actual)

October 28, 2019

Last Update Submitted That Met QC Criteria

October 25, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Constraint-induced movement therapy

3
Subscribe